A new class-action lawsuit alleges CVS Caremark unlawfully changed its coverage for popular GLP-1 drug Zepbound. Earlier this year, Caremark revealed that it would remove Eli Lilly's blockbuster drug ...
The reality—familiar to those who routinely defend large-scale class actions—is that discovery asymmetry is more often deployed against corporate defendants than wielded by them. Proportionality, not ...
NEW YORK (PIX11) – If you bought eye drops at a drug store in the past few years, you may be able to get a piece of a $3.5 million class action settlement. Similason has agreed to pay $3.575 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results